Candida gut commensalism and inflammatory disease

Hill, 2010, Intestinal bacteria and the regulation of immune cell homeostasis, Annu Rev Immunol, 28, 623, 10.1146/annurev-immunol-030409-101330 Savage, 1968, Alterations in the mouse cecum and its flora produced by antibacterial drugs, J Exp Med, 128, 97, 10.1084/jem.128.1.97 Schaedler, 1965, Association of germfree mice with bacteria isolated from normal mice, J Exp Med, 122, 77, 10.1084/jem.122.1.77 Bry, 1996, A model of host-microbial interactions in an open mammalian ecosystem, Science, 273, 1380, 10.1126/science.273.5280.1380 Stappenbeck, 2002, Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells, Proc Natl Acad Sci U S A, 99, 15451, 10.1073/pnas.202604299 Rakoff-Nahoum, 2004, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 118, 229, 10.1016/j.cell.2004.07.002 Wang, 2006, A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2, J Exp Med, 203, 2853, 10.1084/jem.20062008 Bolognini, 2016, The pharmacology and function of receptors for short-chain fatty acids, Mol Pharmacol, 89, 388, 10.1124/mol.115.102301 Sun, 2017, Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases, J Gastroenterol, 52, 1, 10.1007/s00535-016-1242-9 Ivanov, 2009, Induction of intestinal Th17 cells by segmented filamentous bacteria, Cell, 139, 485, 10.1016/j.cell.2009.09.033 Gaboriau-Routhiau, 2009, The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses, Immunity, 31, 677, 10.1016/j.immuni.2009.08.020 Bouskra, 2008, Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis, Nature, 456, 507, 10.1038/nature07450 Mazmanian, 2005, An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system, Cell, 122, 107, 10.1016/j.cell.2005.05.007 Mazmanian, 2008, A microbial symbiosis factor prevents intestinal inflammatory disease, Nature, 453, 620, 10.1038/nature07008 Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Margulies, 2005, Genome sequencing in microfabricated high-density picolitre reactors, Nature, 437, 376, 10.1038/nature03959 Knox, 2019, The gut microbiome as a target for IBD treatment: are we there yet?, Curr Treat Options Gastroenterol, 17, 115, 10.1007/s11938-019-00221-w Angelucci, 2019, Antibiotics, gut microbiota, and Alzheimer's disease, J Neuroinflammation, 16, 108, 10.1186/s12974-019-1494-4 Heiss, 2019, The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system, J Neuroendocrinol, 31, 10.1111/jne.12684 Troncoso-Escudero, 2018, Outside in: unraveling the role of neuroinflammation in the progression of Parkinson's disease, Front Neurol, 9, 860, 10.3389/fneur.2018.00860 Abdel-Haq, 2019, Microbiome-microglia connections via the gut-brain axis, J Exp Med, 216, 41, 10.1084/jem.20180794 Oligschlaeger, 2019, Inflammatory bowel disease: a stressed, Gut/Feeling". Cells, 8 Natale, 2019, TREM receptors connecting bowel inflammation to neurodegenerative disorders, Cells, 8, 10.3390/cells8101124 Aggeletopoulou, 2019, The role of the gut microbiota in the treatment of inflammatory bowel diseases, Microb Pathog, 137, 103774, 10.1016/j.micpath.2019.103774 Janbon, 2019, Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches, Gene Immun, 20, 403, 10.1038/s41435-019-0071-2 Nilsson, 2019, Mycobiome diversity: high-throughput sequencing and identification of fungi, Nat Rev Microbiol, 17, 95, 10.1038/s41579-018-0116-y Steensels, 2019, Domestication of industrial microbes, Curr Biol, 29, R381, 10.1016/j.cub.2019.04.025 Cordente, 2019, Harnessing yeast metabolism of aromatic amino acids for fermented beverage bioflavouring and bioproduction, Appl Microbiol Biotechnol, 103, 4325, 10.1007/s00253-019-09840-w Martel, 2017, Anti-obesogenic and antidiabetic effects of plants and mushrooms, Nat Rev Endocrinol, 13, 149, 10.1038/nrendo.2016.142 Iliev, 2012, Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis, Science, 336, 1314, 10.1126/science.1221789 Scupham, 2006, Abundant and diverse fungal microbiota in the murine intestine, Appl Environ Microbiol, 72, 793, 10.1128/AEM.72.1.793-801.2006 David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820 Richard, 2019, The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases, Nat Rev Gastroenterol Hepatol, 16, 331 Ghannoum, 2010, Characterization of the oral fungal microbiome (mycobiome) in healthy individuals, PLoS Pathog, 6, 10.1371/journal.ppat.1000713 Mukherjee, 2014, Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi, PLoS Pathog, 10, 10.1371/journal.ppat.1003996 Hendrickson, 2019, Antifungal resistance: a concerning trend for the present and future, Curr Infect Dis Rep, 21, 47, 10.1007/s11908-019-0702-9 Jawhara, 2008, Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3, J Infect Dis, 197, 972, 10.1086/528990 Standaert-Vitse, 2009, Candida albicans colonization and ASCA in familial Crohn’s disease, Am J Gastroenterol, 104, 1745, 10.1038/ajg.2009.225 Hoarau, 2016, Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial crohn's disease, mBio, 7, 10.1128/mBio.01250-16 Sokol, 2017, Fungal microbiota dysbiosis in IBD, Gut, 66, 1039, 10.1136/gutjnl-2015-310746 Coker, 2019, Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer, Gut, 68, 654, 10.1136/gutjnl-2018-317178 Standaert-Vitse, 2006, Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn’s disease, Gastroenterology, 130, 1764, 10.1053/j.gastro.2006.02.009 Wheeler, 2016, Immunological consequences of intestinal fungal dysbiosis, Cell Host Microbe, 19, 865, 10.1016/j.chom.2016.05.003 Casadevall, 2012, Fungi and the rise of mammals, PLoS Pathog, 8, 10.1371/journal.ppat.1002808 Nobile, 2015, Candida albicans biofilms and human disease, Annu Rev Microbiol, 69, 71, 10.1146/annurev-micro-091014-104330 Whiteway, 2007, Morphogenesis in Candida albicans, Annu Rev Microbiol, 61, 529, 10.1146/annurev.micro.61.080706.093341 Lo, 1997, Nonfilamentous C. albicans mutants are avirulent, Cell, 90, 939, 10.1016/S0092-8674(00)80358-X Patil, 2015, Clinical appearance of oral Candida infection and therapeutic strategies, Front Microbiol, 6, 1391, 10.3389/fmicb.2015.01391 Auchtung, 2018, Investigating colonization of the healthy adult gastrointestinal tract by fungi, mSphere, 3, 10.1128/mSphere.00092-18 Bacher, 2014, Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi, Mucosal Immunol, 7, 916, 10.1038/mi.2013.107 Bacher, 2019, Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans, Cell, 176, 1340, 10.1016/j.cell.2019.01.041 Nucci, 2001, Revisiting the source of candidemia: skin or gut?, Clin Infect Dis, 33, 1959, 10.1086/323759 Kullberg, 2015, Invasive candidiasis, N Engl J Med, 373, 1445, 10.1056/NEJMra1315399 Dominic, 2007, Candida biofilms in medical devices: evolving trends, Kathmandu Univ Med J, 5, 431 Liu, 2014, Different epidemiology of candidemia in intensive care unit patients at a hospital in Taiwan, J Postgrad Med, 60, 88 Lanternier, 2013, Primary immunodeficiencies underlying fungal infections, Curr Opin Pediatr, 25, 736, 10.1097/MOP.0000000000000031 Puel, 2010, Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?, Curr Opin Immunol, 22, 467, 10.1016/j.coi.2010.06.009 Puel, 2011, Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity, Science, 332, 65, 10.1126/science.1200439 Ling, 2015, Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis, J Exp Med, 212, 619, 10.1084/jem.20141065 Drummond, 2018, Human CARD9: a critical molecule of fungal immune surveillance, Front Immunol, 9, 1836, 10.3389/fimmu.2018.01836 Phan, 2007, Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells, PLoS Biol, 5, e64, 10.1371/journal.pbio.0050064 Moyes, 2016, Candidalysin is a fungal peptide toxin critical for mucosal infection, Nature, 532, 64, 10.1038/nature17625 Richardson, 2018, Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa, Infect Immun, 86, 10.1128/IAI.00645-17 Allert, 2018, Candida albicans-induced epithelial damage mediates translocation through intestinal barriers, mBio, 9, 10.1128/mBio.00915-18 Tsai, 2013, Murinization of internalin extends its receptor repertoire, altering Listeria monocytogenes cell tropism and host responses, PLoS Pathog, 9, 10.1371/journal.ppat.1003381 Nikitas, 2011, Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin, J Exp Med, 208, 2263, 10.1084/jem.20110560 Gessain, 2015, PI3-kinase activation is critical for host barrier permissiveness to Listeria monocytogenes, J Exp Med, 212, 165, 10.1084/jem.20141406 Bartels, 1945, The isolation of Candida albicans from a root canal undergoing penicillin therapy, J Dent Res, 24, 315, 10.1177/00220345450240060601 Lipnik, 1952, Antibiotics and fungous infections, J Invest Dermatol, 18, 247, 10.1038/jid.1952.28 Koh, 2008, Mucosal damage and neutropenia are required for Candida albicans dissemination, PLoS Pathog, 4, e35, 10.1371/journal.ppat.0040035 Fan, 2015, Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization, Nat Med, 21, 808, 10.1038/nm.3871 Zelante, 2013, Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22, Immunity, 39, 372, 10.1016/j.immuni.2013.08.003 Sovran, 2018, Enterobacteriaceae are essential for the modulation of colitis severity by fungi, Microbiome, 6, 152, 10.1186/s40168-018-0538-9 Bandara, 2009, Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation, J Med Microbiol, 58, 1623, 10.1099/jmm.0.012989-0 Erb Downward, 2013, Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans, Sci Rep, 3, 2191, 10.1038/srep02191 Zuo, 2018, Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection, Nat Commun, 9, 3663, 10.1038/s41467-018-06103-6 Raponi, 2014, Clostridium difficile infection and Candida colonization of the gut: is there a correlation?, Clin Infect Dis, 59, 1648, 10.1093/cid/ciu637 Main, 1988, Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease, BMJ, 297, 1105, 10.1136/bmj.297.6656.1105 Sendid, 1998, Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn’s disease, Am J Gastroenterol, 93, 1306, 10.1111/j.1572-0241.1998.00415.x Mertz, 2019, Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence, Ann Gastroenterol, 32, 124 Ruhlemann, 2019 Lemoinne, 2020, Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis, Gut, 69, 92, 10.1136/gutjnl-2018-317791 Yang, 2017, Intestinal fungi contribute to development of alcoholic liver disease, J Clin Invest, 127, 2829, 10.1172/JCI90562 Li, 2014, Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease, J Clin Gastroenterol, 48, 513, 10.1097/MCG.0000000000000035 Leonardi, 2018, CX3CR1(+) mononuclear phagocytes control immunity to intestinal fungi, Science, 359, 232, 10.1126/science.aao1503 Gow, 2011, Candida albicans morphogenesis and host defence: discriminating invasion from colonization, Nat Rev Microbiol, 10, 112, 10.1038/nrmicro2711 Conti, 2015, IL-17-Mediated immunity to the opportunistic fungal pathogen Candida albicans, J Immunol, 195, 780, 10.4049/jimmunol.1500909 Lionakis, 2017, Immunity against fungi, JCI Insight, 2, 10.1172/jci.insight.93156 Vautier, 2015, Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity, Cell Microbiol, 17, 445, 10.1111/cmi.12388 Fujino, 2003, Increased expression of interleukin 17 in inflammatory bowel disease, Gut, 52, 65, 10.1136/gut.52.1.65 Moschen, 2019, IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting, Nat Rev Gastroenterol Hepatol, 16, 185, 10.1038/s41575-018-0084-8 Qiu, 2017, Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis, Oncotarget, 8, 107577, 10.18632/oncotarget.22534 Shao, 2019, Commensal Candida albicans positively calibrates systemic Th17 immunological responses, Cell Host Microbe, 25, 404, 10.1016/j.chom.2019.02.004 Koivikko, 1988, Relationship of immediate and delayed hypersensitivity to nasopharyngeal and intestinal growth of Candida albicans in allergic subjects, Allergy, 43, 201, 10.1111/j.1398-9995.1988.tb00419.x Dismukes, 1990, A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome, N Engl J Med, 323, 1717, 10.1056/NEJM199012203232501 Savolainen, 1993, Candida albicans and atopic dermatitis, Clin Exp Allergy, 23, 332, 10.1111/j.1365-2222.1993.tb00331.x Savolainen, 1998, IgE, IgA, and IgG responses to common yeasts in atopic patients, Allergy, 53, 506, 10.1111/j.1398-9995.1998.tb04088.x Faergemann, 2002, Atopic dermatitis and fungi, Clin Microbiol Rev, 15, 545, 10.1128/CMR.15.4.545-563.2002 Noverr, 2004, Role of antibiotics and fungal microbiota in driving pulmonary allergic responses, Infect Immun, 72, 4996, 10.1128/IAI.72.9.4996-5003.2004 Fujimura, 2016, Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation, Nat Med, 22, 1187, 10.1038/nm.4176 Wang, 2011, The potential role of interleukin-17 in severe asthma, Curr Allergy Asthma Rep, 11, 388, 10.1007/s11882-011-0210-y Chien, 2013, Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity, Clin Exp Allergy, 43, 1018, 10.1111/cea.12119 Choy, 2015, TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma, Sci Transl Med, 7, 301ra129, 10.1126/scitranslmed.aab3142 Tan, 2011, The Th17 pathway in cystic fibrosis lung disease, Am J Respir Crit Care Med, 184, 252, 10.1164/rccm.201102-0236OC Ponce-Gallegos, 2017, Th17 profile in COPD exacerbations, Int J Chronic Obstr Pulm Dis, 12, 1857, 10.2147/COPD.S136592 Jayasudha, 2019, Implicating dysbiosis of the gut fungal microbiome in uveitis, an inflammatory disease of the eye, Invest Ophthalmol Vis Sci, 60, 1384, 10.1167/iovs.18-26426 Li, 2019, Altered bacterial-fungal interkingdom networks in the guts of ankylosing spondylitis patients, mSystems, 4, 10.1128/mSystems.00176-18 Jethwa, 2016, The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment, Clin Exp Immunol, 183, 30, 10.1111/cei.12670 Amadi-Obi, 2007, TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1, Nat Med, 13, 711, 10.1038/nm1585 Marakalala, 2013, Differential adaptation of Candida albicans in vivo modulates immune recognition by Dectin-1, PLoS Pathog, 9, 10.1371/annotation/7821bda1-dde3-4e72-b688-447b6bca20ea Maury, 2017, Erratum: uncovering Listeria monocytogenes hypervirulence by harnessing its biodiversity, Nat Genet, 49, 970, 10.1038/ng0617-970d Liang, 2019, Hemizygosity enables a mutational transition governing fungal virulence and commensalism, Cell Host Microbe, 25, 418, 10.1016/j.chom.2019.01.005 Bohm, 2017, The yeast form of the fungus Candida albicans promotes persistence in the gut of gnotobiotic mice, PLoS Pathog, 13, 10.1371/journal.ppat.1006699 Witchley, 2019, Candida albicans morphogenesis programs control the balance between gut commensalism and invasive infection, Cell Host Microbe, 25, 432, 10.1016/j.chom.2019.02.008 Tso, 2018, Experimental evolution of a fungal pathogen into a gut symbiont, Science, 362, 589, 10.1126/science.aat0537 Chehoud, 2015, Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease, Inflamm Bowel Dis, 21, 1948, 10.1097/MIB.0000000000000454 Liguori, 2016, Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients, J Crohns Colitis, 10, 296, 10.1093/ecco-jcc/jjv209 Muratori, 2003, Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases, Clin Exp Immunol, 132, 473, 10.1046/j.1365-2249.2003.02166.x Katt, 2013, Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis, Hepatology, 58, 1084, 10.1002/hep.26447 Takemoto, 2015, Molecular characterization of the skin fungal microbiome in patients with psoriasis, J Dermatol, 42, 166, 10.1111/1346-8138.12739 Naik, 2017, Th17 inhibitors in active psoriatic arthritis: a systematic review and meta-analysis of randomized controlled clinical trials, Dermatology, 233, 366, 10.1159/000484520 Chang, 2018, Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization, Microbiome, 6, 154, 10.1186/s40168-018-0533-1 Stehlikova, 2019, Dysbiosis of skin microbiota in psoriatic patients: Co-occurrence of fungal and bacterial communities, Front Microbiol, 10, 438, 10.3389/fmicb.2019.00438 Willger, 2014, Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis, Microbiome, 2, 40, 10.1186/2049-2618-2-40 Fraczek, 2018, Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease, J Allergy Clin Immunol, 142, 407, 10.1016/j.jaci.2017.09.039